[68Ga]DOTATATE-PET/MRI in Hepatocellular Carcinoma to Assess the Feasibility of Targeted Radionuclide Therapy With Somatostatin Receptor Ligands
Phase of Trial: Phase I/II
Latest Information Update: 01 Apr 2019
Price : $35 *
At a glance
- Drugs Gallium 68-DOTATATE (Primary)
- Indications Liver cancer
- Focus Diagnostic use
- 25 Mar 2019 Status changed from not yet recruiting to recruiting.
- 07 Jan 2019 Planned End Date changed from 3 Dec 2019 to 1 Mar 2020.
- 07 Jan 2019 Planned primary completion date changed from 3 Dec 2019 to 1 Mar 2020.